title: Erythema marginatum hemorrhagicum: a unique cutaneous side effect of sorafenib.
authors.forename: Katharina
authors.initials: K
authors.lastname: Rübsam
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Flaig
authors.forename: Thomas
authors.initials: T
authors.lastname: Ruzicka
authors.forename: Jörg C
authors.initials: JC
authors.lastname: Prinz
mesh_terms: D000368:Aged; D001557:Benzenesulfonates / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D004890:Erythema / Q000139:chemically induced* / Q000473:pathology; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000009:adverse effects*; D000077157:Sorafenib; D009626:Terminology as Topic
chemical_list: D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib